The COVID-19 pandemic significantly transformed the pharmaceutical industry, particularly in marketing strategies. Traditional face-to-face interactions were replaced by digital engagement, reshaping how pharmaceutical companies interact with healthcare professionals (HCPs) and patients. This review explores post-pandemic pharmaceutical marketing trends, including digital transformation, omnichannel marketing, telemedicine integration, data-driven personalization, patient-centric approaches, and regulatory changes. The study synthesizes recent literature to provide insights into evolving marketing strategies and future directions.
Kumar et al. (Wed,) studied this question.